BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carli M, Kolachalam S, Longoni B, Pintaudi A, Baldini M, Aringhieri S, Fasciani I, Annibale P, Maggio R, Scarselli M. Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences. Pharmaceuticals (Basel) 2021;14:238. [PMID: 33800403 DOI: 10.3390/ph14030238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Rothschild AJ. Should Antipsychotic Medications Be Prescribed to Patients With Nonpsychotic Depression? J Clin Psychopharmacol 2022;42:231-3. [PMID: 35475846 DOI: 10.1097/JCP.0000000000001550] [Reference Citation Analysis]
2 Belardo C, Alessio N, Pagano M, De Dominicis E, Infantino R, Perrone M, Iannotta M, Galderisi U, Rinaldi B, Scuteri D, Bagetta G, Palazzo E, Maione S, Luongo L. PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation. Neuropharmacology 2022. [DOI: 10.1016/j.neuropharm.2022.108978] [Reference Citation Analysis]
3 Alvarez-Mon MA, Donat-Vargas C, Santoma-Vilaclara J, de Anta L, Goena J, Sanchez-Bayona R, Mora F, Ortega MA, Lahera G, Rodriguez-Jimenez R, Quintero J, Álvarez-Mon M. Assessment of Antipsychotic Medications on Social Media: Machine Learning Study. Front Psychiatry 2021;12:737684. [PMID: 34867531 DOI: 10.3389/fpsyt.2021.737684] [Reference Citation Analysis]
4 Goh KK, Chen CY, Wu T, Chen C, Lu M. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction. IJMS 2022;23:7092. [DOI: 10.3390/ijms23137092] [Reference Citation Analysis]
5 Swathy B, Banerjee M. Understanding Pharmaco-Epigenomic Response of Antipsychotic Drugs Using Genome-Wide MicroRNA Expression Profile in Liver Cell Line. Front Mol Neurosci 2022;15:786632. [DOI: 10.3389/fnmol.2022.786632] [Reference Citation Analysis]
6 Banerjee M. Pharmacoepigenomics: a key determinant in resolving epigenomic parameters in pathogenesis, and treatment response in complex diseases. Pharmacogenomics 2021. [PMID: 34842441 DOI: 10.2217/pgs-2021-0140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Vanwong N, Sukasem C, Unaharassamee W, Jiratjintana N, Na Nakorn C, Hongkaew Y, Puangpetch A. Associations of the SREBF2 Gene and INSIG2 Polymorphisms with Obesity and Dyslipidemia in Thai Psychotic Disorder Patients Treated with Risperidone. J Pers Med 2021;11:943. [PMID: 34683084 DOI: 10.3390/jpm11100943] [Reference Citation Analysis]
8 Desouza CV, Johnson-Rabbett BE, Gajewski B, Brown A, Ellerbeck EF, VanWormer JJ, Befort C. The effect of nonpharmaceutical weight-loss interventions in rural patients with diabetes: RE-POWER Diabetes. Obesity (Silver Spring) 2022. [PMID: 35275606 DOI: 10.1002/oby.23392] [Reference Citation Analysis]
9 Gupta B, Chee KS, Neo LQ, Tang C, Hariram J, Tan GC, Verma S, Basu S, Appan DP, Ting CC, Abdin E, Lee J. Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial. Ther Adv Psychopharmacol 2021;11:20451253211046765. [PMID: 34646440 DOI: 10.1177/20451253211046765] [Reference Citation Analysis]
10 Fukuyama K, Motomura E, Okada M. Brexpiprazole Reduces 5-HT7 Receptor Function on Astroglial Transmission Systems. Int J Mol Sci 2022;23:6571. [PMID: 35743014 DOI: 10.3390/ijms23126571] [Reference Citation Analysis]
11 Boiko AS, Mednova IA, Kornetova EG, Gerasimova VI, Kornetov AN, Loonen AJM, Bokhan NA, Ivanova SA. Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics. Pharmaceuticals (Basel) 2021;14:446. [PMID: 34065135 DOI: 10.3390/ph14050446] [Reference Citation Analysis]
12 Lee K, Abraham S, Cleaver R. A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis. Gen Hosp Psychiatry 2022;78:58-67. [PMID: 35863294 DOI: 10.1016/j.genhosppsych.2022.07.006] [Reference Citation Analysis]
13 Carli M, Risaliti E, Francomano M, Kolachalam S, Longoni B, Bocci G, Maggio R, Scarselli M. A 5-Year Study of Lithium and Valproic Acid Drug Monitoring in Patients with Bipolar Disorders in an Italian Clinical Center. Pharmaceuticals 2022;15:105. [DOI: 10.3390/ph15010105] [Reference Citation Analysis]
14 Seeman MV, González-Rodríguez A. Stratification by Sex and Hormone Level When Contrasting Men and Women in Schizophrenia Trials Will Improve Personalized Treatment. J Pers Med 2021;11:929. [PMID: 34575706 DOI: 10.3390/jpm11090929] [Reference Citation Analysis]
15 Wang J, Wu Q, Zhou Y, Yu L, Yu L, Deng Y, Tu C, Li W. The mechanisms underlying olanzapine-induced insulin resistance via the brown adipose tissue and the therapy in rats. Adipocyte 2022;11:84-98. [PMID: 35067163 DOI: 10.1080/21623945.2022.2026590] [Reference Citation Analysis]